| No images? Click here  Thursday, 18 December 2025 Note to media Updated COVID-19 vaccine composition recommendation The World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) has issued updated recommendations. The objective of the updated vaccine composition is to enhance immune responses against circulating variants and provide broader protection, as SARS-CoV-2, the virus that causes COVID-19, continues to evolve. TAG-CO-VAC advises manufacturers that monovalent LP.8.1 is the recommended antigen for COVID-19 vaccines. Previously recommended antigens from the JN.1 lineage (JN.1 or KP.2) remain suitable alternatives. Vaccination remains important and should not be delayed while awaiting LP.8.1-based vaccines. TAG-CO-VAC is an independent group of experts that advises WHO on vaccine composition. They convened in December 2025 for their twice-yearly meeting to review the evolution of SARS-CoV-2 variants; immune responses to SARS-CoV-2 infection and COVID-19 vaccination; and the performance of vaccine products against circulating variants. Read the technical statement.  Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
0 Comments